PAH Treatment Options: A Concise Summary

Release date: 12/15/2022

Expiration date: 12/15/2023

Program Overview: A non-accredited educational activity to summarize the current treatment options for pulmonary artery disease.

Target Audience: Cardiologists, pulmonologists, nurse practitioners, physician assistants, nurses and other providers involved in the management of patients with pulmonary arterial hypertension (PAH)

Learning Objective:

Summarize current treatment options for pulmonary arterial hypertension.


Deborah C. Clark, PhD Senior Director of Professional Development

Commercial Support:

Supported by an educational grant from Merck Sharp & Dohme LLC a subsidiary of Merck & Co., Inc.